1. Home
  2. MBIO vs ONFO Comparison

MBIO vs ONFO Comparison

Compare MBIO & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • ONFO
  • Stock Information
  • Founded
  • MBIO 2015
  • ONFO 2018
  • Country
  • MBIO United States
  • ONFO United States
  • Employees
  • MBIO N/A
  • ONFO N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • ONFO Computer Software: Programming Data Processing
  • Sector
  • MBIO Health Care
  • ONFO Technology
  • Exchange
  • MBIO Nasdaq
  • ONFO Nasdaq
  • Market Cap
  • MBIO 4.7M
  • ONFO 5.0M
  • IPO Year
  • MBIO N/A
  • ONFO 2022
  • Fundamental
  • Price
  • MBIO $1.28
  • ONFO $0.80
  • Analyst Decision
  • MBIO
  • ONFO
  • Analyst Count
  • MBIO 0
  • ONFO 0
  • Target Price
  • MBIO N/A
  • ONFO N/A
  • AVG Volume (30 Days)
  • MBIO 90.7K
  • ONFO 1.6M
  • Earning Date
  • MBIO 11-07-2025
  • ONFO 11-17-2025
  • Dividend Yield
  • MBIO N/A
  • ONFO N/A
  • EPS Growth
  • MBIO N/A
  • ONFO N/A
  • EPS
  • MBIO N/A
  • ONFO N/A
  • Revenue
  • MBIO N/A
  • ONFO $11,238,989.00
  • Revenue This Year
  • MBIO N/A
  • ONFO N/A
  • Revenue Next Year
  • MBIO N/A
  • ONFO N/A
  • P/E Ratio
  • MBIO N/A
  • ONFO N/A
  • Revenue Growth
  • MBIO N/A
  • ONFO 70.54
  • 52 Week Low
  • MBIO $0.89
  • ONFO $0.60
  • 52 Week High
  • MBIO $21.95
  • ONFO $1.95
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 45.30
  • ONFO 37.60
  • Support Level
  • MBIO $1.13
  • ONFO $0.60
  • Resistance Level
  • MBIO $1.20
  • ONFO $0.81
  • Average True Range (ATR)
  • MBIO 0.08
  • ONFO 0.11
  • MACD
  • MBIO 0.01
  • ONFO -0.03
  • Stochastic Oscillator
  • MBIO 62.05
  • ONFO 29.13

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About ONFO Onfolio Holdings Inc.

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.

Share on Social Networks: